This inflammatory response is part of a broader tumor-induced immune disruption, which also includes enhanced lymphangiogenesis and lymphatic remodeling, driven by VEGFC and VEGFD, facilitating tumor dissemination. This evidence concerns the gene VEGFD and neoplasm.